Dr. Shalini Mehta, MD

Dr. Mehta practices at Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System.

Dr. Mehta's NPI, 1093126757, was assigned on May 15, 2014. Dr. Mehta holds Oregon license MD214969.

Dr. Mehta's primary practice is Good Samaritan Regional Medical Center, at 3600 NW Samaritan Drive, Corvallis, OR 97339 in Benton County. The practice phone is (541) 768-5111.

Dr. Mehta's primary practice is Good Samaritan Regional Medical Center in Corvallis, Oregon, part of MultiCare Health System. Dr. Mehta is also affiliated with Samaritan Albany General Hospital. The medical group on file is Good Samaritan Regional Medical Center. Dmand AI also links Dr. Mehta to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Mehta's licenses on file in 2 states: Oregon and Oklahoma.

CMS data shows 477 Medicare services from Dr. Mehta across 14 procedure codes in 2024, for 210 Medicare patients. Medicare paid $39,170 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 210 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 93 patients. 74% of them have high blood pressure, and 65% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 70, with 59% women.

In 2024, Dr. Mehta wrote 677 Medicare Part D claims for 143 patients. 44% of them were for generic drugs. CMS names the drug for 466 of them, across 15 drugs with 11 or more claims each, at $222,881 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

Dmand AI links 1 paper to Dr. Mehta in 2023. Dr. Mehta's most frequent co-authors are Maxwell Johannes Diddams, MD and Christina Renee Macrosty, DO.

CMS Open Payments shows 58 general payments to Dr. Mehta from 17 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 62% of the total. Noah Medical Corporation paid the most, $4,259.